Results 211 to 220 of about 20,614 (289)

Real-world analysis of integration of sacubitril/valsartan into clinical practice in Saudi Arabia

, 2023
Hisham A. Badreldin, Ghazwa B. Korayem, Basel Alenazy, Mousa H. Aljohani, Omar A. Alshaya, Khalid Al Sulaiman, Lolwa Al-Abdelmuhsin, Huda Alenazi, Dahlia M. Almutairi, Faisal Alanazi, Seba K. Alobathani, Ghada Alqannam, Ohoud Almadani, Ohoud Aljuhani, Awatif Hafiz, Ghalyah Aljowaie, Ehssan Basha, Tariq Alqahtani, Mosaad Alhussein   +18 more
openalex   +1 more source

Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.

Journal of the American College of Cardiology
David A. Morrow, Eric J. Velazquez, A. Desai, A. DeVore, S. Lepage, Jeon-Gun Park, K. Sharma, Scott D. Solomon, Randall C. Starling, Jonathan H. Ward, Kristin M. Williamson, S. Zieroth, Adrian F. Hernandez, Robert J. Mentz, Eugene Braunwald   +14 more
semanticscholar   +1 more source

A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Wang S, Lai J, Chen J, Luo Q, Yi W, Lai Y.   +5 more
europepmc   +1 more source

Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

JACC Adv
Kido K, Hashiguchi M, Guglin M.
europepmc   +1 more source

Effects and safety of Sacubitril/Valsartan (SV) on heart function and blood pressure in maintenance hemodialysis (MHD) patients.

, 2022
Yang Wen, Yunfeng Xia, Ying Gong
openalex   +1 more source

A propensity score-matched retrospective study on sacubitril/valsartan use and 6-month readmission rates in patients with acute heart failure. [PDF]

PeerJ
Zhang L, Chen Q, Ren G.
europepmc   +1 more source

A sensitive green HPLC-fluorescence method for simultaneous analysis of sacubitril and valsartan in pure forms, pharmaceutical dosage form and human plasma. [PDF]

Sci Rep
Kormod LA, Hegazy MA, Kessiba AM.
europepmc   +1 more source

Early sacubitril/valsartan use associated with reduced atrial fibrillation risk in patients with acute myocardial infarction complicated by mitral regurgitation: a retrospective cohort study. [PDF]

Front Cardiovasc Med
Yin H, Zhou Y, Zhou Y, Ren L, Ma L.
europepmc   +1 more source

Impact of Predischarge NT-proBNP on Treatment Optimisation in Acute Heart Failure. [PDF]

Int J Mol Sci
Polovina M, Tomić M, Janković M, Civrić D, Stojićević A, Stanković S, Pejović T, Viduljević M, Krljanac G, Ašanin M, Stanković S, Seferović PM.   +11 more
europepmc   +1 more source

Improvement in Right Ventricular Function and Pulmonary Pressures in Patients With Severe Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction Treated With Sacubitril-Valsartan. [PDF]

Pulm Circ
Abofrekha B, Jdaidani J, Shadi M, Sanayeh EB, Agarwal A, Zaidan N, Rojas-Marte GR.   +6 more
europepmc   +1 more source